- Condition: Coronary Artery Disease
Intervention:
Sponsors: University of Saskatchewan; University of Saskatchewan
Enrolling by invitation - verified May 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Tranexamic Acid; Drug: normal saline
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatoon Health Region
Active, not recruiting - verified May 2012 - Conditions: Diabetes Mellitus, Type 2; Hypercholesterolemia
Intervention: Other: BeneFlax - 38% secoisolariciresinol diglucoside (SDG)
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified February 2012 - Condition: Hypotension
Intervention: Device: Ultrasound
Sponsors: Saint John Regional Hospital; Saint John Regional Hospital
Recruiting - verified March 2012 - Condition: Grief
Intervention: Behavioral: Writing Intervention
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatoon Health Region
Recruiting - verified August 2011 - Conditions: Postpartum Hemorrhage; Uterine Atony
Interventions: Drug: Oxytocin; Drug: Saline
Sponsors: University of Saskatchewan; University of Saskatchewan
Withdrawn - verified October 2011 - Conditions: Oxidative Stress; Inflammation; Aging; Dementia; Pain
Intervention: Dietary Supplement: secoisolariciresinol diglucoside
Sponsors: University of Saskatchewan; University of Saskatchewan; Saskatchewan Health Research Foundation
Recruiting - verified October 2011 - Condition: Aging
Intervention:
Sponsors: University of Saskatchewan; University of Saskatchewan; Canadian Foundation for Women's Health
Completed - verified August 2011 - Conditions: Asthma; Allergic Rhinitis
Intervention:
Sponsors: University of British Columbia; University of British Columbia; Allergy, Genes and Environment Network (AllerGen); Networks of Centres of Excellence (NCE)
Recruiting - verified November 2011 - Conditions: Osteoporosis; Sarcopenia
Interventions: Dietary Supplement: creatine monohydrate; Dietary Supplement: sugar placebo
Sponsors: University of Saskatchewan; University of Saskatchewan
Active, not recruiting - verified September 2011 - Conditions: Failed Back Surgery Syndrome; Leg Pain; Back Pain; Spinal Cord Stimulation
Interventions: Device: Precision Spinal Cord Stimulation; Procedure: Back Surgery
Sponsors: Boston Scientific Corporation; Boston Scientific Corporation
Recruiting - verified March 2012 - Conditions: Prostate Cancer; Sexual Dysfunction
Interventions: Drug: tadalafil; Other: placebo
Sponsors: National Cancer Institute (NCI); Radiation Therapy Oncology Group; National Cancer Institute (NCI)
Active, not recruiting - verified February 2012 - Condition: Primary Dysmenorrhea
Interventions: Drug: Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027); Drug: Ethinyl estradiol, Levonorgestrel (Miranova)
Sponsors: Bayer; Bayer
Completed - verified January 2012 - Condition: Anti-biotic Resistance
Interventions: Drug: moxifloxacin 0.5% HCI ophthalmic solution; Drug: gatifloxacin ophthalmic solution 0.3%
Sponsors: Allergan; Allergan
Completed - verified November 2011 - Conditions: Smoking Cessation; Insurance Coverage
Interventions: Other: Full Smoking Cessation Treatment Coverage (100%); Other: No Smoking Cessation Treatment Coverage (0%)
Sponsors: Pfizer; Pfizer
Completed - verified February 2012 - Condition: Metabolic Syndrome
Interventions: Behavioral: Aerobic exercise training; Dietary Supplement: pulse based diet
Sponsors: University of Saskatchewan; University of Saskatchewan
Completed - verified September 2011 - Condition: Contraception
Interventions: Drug: Qlaira (BAY86-5027, SH T00658ID); Drug: Ortho Tri Cyclen Lo
Sponsors: Bayer; Bayer
Completed - verified July 2011 - Conditions: Acute Coronary Syndrome; Myocardial Infarction; Smoking
Interventions: Drug: Bupropion HCl ER; Drug: Placebo
Sponsors: McGill University; Mark Eisenberg; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Quebec
Completed - verified May 2008 - Conditions: Respiratory Syncytial Virus (RSV); Parainfluenza Virus Type 3 (PIV3)
Interventions: Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: MEDI-534; Biological: Placebo
Sponsors: MedImmune LLC; MedImmune LLC
Active, not recruiting - verified May 2012 - Condition: Meningococcal Infections
Interventions: Biological: MenACWY-CRM; Biological: MenACWY-CRM; Biological: Licensed meningococcal ACWY vaccine
Sponsors: Novartis; Novartis Vaccines
Completed - verified December 2011 - Condition: Influenza
Interventions: Drug: oseltamivir; Drug: oseltamivir; Other: Alternative Control
Sponsors: Hoffmann-La Roche; Hoffmann-La Roche
Recruiting - verified May 2012 - Condition: Contraception
Interventions: Drug: G04209F; Drug: G04209G
Sponsors: Bayer; Bayer
Active, not recruiting - verified April 2012 - Conditions: Osteoporosis; Osteopenia
Intervention: Dietary Supplement: exercise/soy isoflavone
Sponsors: University of Saskatchewan; University of Saskatchewan; Canadian Institutes of Health Research (CIHR)
Completed - verified September 2011 - Condition: Leukemia
Interventions: Biological: filgrastim; Drug: asparaginase; Drug: cyclophosphamide; Drug: cyclosporine; Drug: cytarabine; Drug: daunorubicin hydrochloride; Drug: dexamethasone; Drug: etoposide; Drug: ifosfamide; Drug: imatinib mesylate; Drug: leucovorin calcium; Drug: mercaptopurine; Drug: methotrexate; Drug: pegaspargase; Drug: vincristine sulfate; Procedure: allogeneic bone marrow transplantation; Procedure: peripheral blood stem cell transplantation; Procedure: umbilical cord blood transplantation; Radiation: radiation therapy
Sponsors: National Cancer Institute (NCI); Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified November 2010
 |
Join Clinical Trials for Healthy Volunteers in Saskatchewan |
